Title: Unsupervised Pills: Who are Likely to Consume?
Authors: Dr Neha Singh, Dr Meenakshi Rana, Dr Sanjay Rathod
DOI: https://dx.doi.org/10.18535/jmscr/v9i12.31
Abstract
Background: Federation of obstetrics and gynecological societies of indi(FOGSI) recommends close monitoring of distribution of drugs that are used for medical abortion and that the medical profession and pharmaceutical industry should excise due diligence in the promotion and usage of drugs that are used for medical abortion. Despite this, it has been perceived by the society that, medical abortion are extremely safe option even in hands of untrained personel, leading to its over the counter dispensing and possibly increase in unsupervised terminations and life threatening complications.
Objective: To Study the demographic profile of women consuming unsupervised abortion pills
Study Design: Prospective Observational Study
Study Settings: This study is to be conducted at Kamla Nehru State Hospital for Mother and Child , IGMC Shimla.
Study Period: 1st July 2018 - 30th June 2019
Inclusion Criteria
All women who have consumed unsupervised abortion pills and reported to the hospital.
Exclusion Criteria
Women coming with Spontaneous abortion, Missed abortion and Blighted ovum.
Results: Data was collected from 121 patients who had history of self medication of abortion pills.74% women were in age group 21-30 years and 88.4% were married. uneducated women were 5%.93% were multigravidas. Source of procurement of drug was seen to be chemist in 79.3% .7 (6%) of the patients in the study used the pills between 9-12 weeks of gestation and another 13(11%) used it after 12 weeks. Conclusion: Health care and health protection is every women’s right. Every women must be counseled regarding advantages, drawbacks, risk and limitations of different method of abortion. awareness on contraceptives is must for all. The chemist also needs to be aware about the MTP act and consequences of medicines that are taken without medical supervision. training on various regimes and advancement is also required for the medical practitioner.
References
- Munshi KS, Thaker RV, Shah JM, Mewada BN. Self-medication of abortion pills and its complication: an observational study. Int J Reprod Contracept Obstet Gynecol 2018; 7:205-9.
- Agarwal M, Datta A. How safe are over the counter abortion pills-differences between its intended and practical usage and its implications- a study conducted in a tertiary care centre in Shillong, Meghalaya, India. Int J Reprod Contracept Obstet Gynecol 2016; 5:3036-4.
- Sarojini, Ashakiran TR, Bhanu BT, Radhika. Over the counter MTP pills and its impact on Women’s Health. J Obstet Gynecol India 2017; 67(1):37-41.
- Government of India. The Medical Termination of pregnancy act, no.34;1971. Available from: http://tcw.nic.in/acts/MTP-act-1971. Pdf Assessed on 26/06/2018.
- Government of India. The medical Termination of pregnancy Rules (Amendment); 2002. Available from: https://mohfw.gov.in/acts-rules-and-standards-health.../acts/MTP-act-amendment-2002. Assessed on June 26, 2018.
- Singh B, Garg R, Kaur P, Kaur B, Kumari S. Abuse of MTP pill without prescription: an analytical study. European J Pharmacet Med Res 2017; 4(8):357-61.
- Giri A, Srivastav VR, Suwal A, Sharma B. A study of Complications following self administration with Medical Abortion Pills. Nepal J Obstet Gynecol 2015; 19(1):20-4.
- Ahman E, Shah IH. New estimates and trends regarding unsafe abortion mortality. Int J Gynecol Obstet 2011; 115(2):121-6.
- Nivedita K, Shanthini F. Is it safe to Provide Abortion Pills over the counter? A Study on Outcome Following Self Medication with Abortion Pills. J Clin Diagn Res 2015; 9(1):01-4.
- Family welfare statistics in India. Ministry of Family Welfare and Health, Govt. Of India, 2011. Available from http://www.mohfw.nic.in/WriteRead Data/1892s/3503492088 FWStatistics 2011 Revised 31 10 11.pdf.
- Bajwa SK, Bajwa SJS, Ghai GK, Singh N, Singh A, Goraya SPS. Medical abortion: Is it a blessing or curse for the developing nations?. Srilanka J Obstet Gynecol 2011; 33(3):84-90.